Heart Rate5 min read

CardioMood PPG: The Technology Behind Accurate Heart Monitoring

Matthias BurelJune 19, 2023
CardioMood PPG: The Technology Behind Accurate Heart Monitoring

CardioMood use high accuracy PPG technology to measure your heart parameters. The major advantage is that PPG is non-invasive and avoids electrodes. Until recently, ECG was considered the gold standard, but compliance with ECG is low. Typically, users cannot stand the electrode sticker for more than 3-5 days. Other known issues are drying-out electrodes whereafter the signal gets (very) bad. The future is high accuracy PPG for long-term continuous monitoring. We also want to monitor long-term as this gives the best baseline to increase performance and determine changes over time.

The accuracy of CardioWatch 287 with pulse detection using photoplethysmography technology in cardiac patients was studied by S. Blok, M.A. Piek, I.I. Tulevski, G.A. Somsen, M.M. Winter. In this single-centre prospective study, patients from an outpatient cardiology clinic underwent a simultaneous resting ECG and PPG recording. 180 patients a total of 7,914 ECG beats were recorded and 7,880 (99%) were also recorded by PPG.

The PPG-accuracy, defined as the proportion of PPG measurements within 100 ms of ECG measurements, was 94.6% (95%CI 94.1-95.1).

Correlation was high for HR (R = 0.991 (95%CI 0.988-0.993), n = 180). The 95% Limits of Agreement (LoA) were -3.89 to 3.77 (mean bias -0.06) beats per minute. The RR-intervals on the PPG were highly correlated with those on the ECG (R = 0.966 (95%CI 0.964-0.968), n = 6,139), with a narrow 95% LoA of -85 to 85 (mean bias -1) ms.

This study showed that the 287 Bracelet with PPG-technology can determine HR and RR-intervals with high accuracy in cardiovascular at-risk patient population among different subgroups.

THE ACCURACY OF HEARTBEAT DETECTION USING PHOTOPLETHYSMOGRAPHY TECHNOLOGY IN CARDIAC PATIENTS

This validation study showed that the 287 CardioWatch/Bracelet with PPG-technology can determine HR and RR-intervals with high accuracy in a cardiovascular patient population, with high quality output in different subgroups, especially when combined with a signal quality indicator. Due to their non-intrusive and convenient nature, wearable devices like these have great potential for high volume accessible long-term monitoring at-risk cardiac patients.

RESEARCH PORTAL

CardioMood is not just a bracelet with an App, we offer an extensive Research Portal to analyze HRV and other vital parameters. Portal: https://study.cardiomood.com/

REFERENCES

  1. Department of Cardiology, Cardiology Centers of the Netherlands. Karel du Jardinstraat 61, Amsterdam, the Netherlands
  2. Department of Vascular Medicine, Internal medicine, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, The Netherlands
  3. Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, The Netherlands
MB

Matthias Burel

CardioMood Team